Price
$440.98
Decreased by -0.69%
Dollar Volume (20D)
1.41 M
ADR%
1.49
Earnings Report Date (estimate)
Nov 6, 23 (N/A)
Market Cap.
775.97 M
Shares Float
1.34 M
Shares Outstanding
1.76 M
Beta
0.51
Price / Earnings
28.75
BPR
0.08
20D Range
439.01 474.75
50D Range
439.01 593.00
200D Range
439.01 705.74
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 4, 10 2.66
Increased by +15.65%
2.50
Increased by +6.40%
Aug 4, 10 2.67
Increased by +29.61%
2.28
Increased by +17.11%
Feb 19, 10 2.10 2.22
Decreased by -5.41%
Nov 4, 09 2.20 2.16
Increased by +1.85%
Aug 3, 09 2.30 2.14
Increased by +7.48%
May 7, 09 2.06 1.93
Increased by +6.74%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 23 43.84 M
Decreased by -10.32%
6.56 M
Decreased by -29.79%
Increased by +14.97%
Decreased by -21.71%
Mar 31, 23 39.99 M
Decreased by -15.16%
3.48 M
Decreased by -59.00%
Increased by +8.71%
Decreased by -51.67%
Dec 31, 22 42.85 M
Increased by +6.36%
8.32 M
Increased by +2.40%
Increased by +19.42%
Decreased by -3.72%
Sep 30, 22 44.63 M
Increased by +4.14%
8.84 M
Increased by +6.79%
Increased by +19.80%
Increased by +2.54%
Jun 30, 22 48.88 M
Increased by +14.50%
9.35 M
Increased by +4.75%
Increased by +19.12%
Decreased by -8.51%
Mar 31, 22 47.14 M
Increased by +20.35%
8.50 M
Increased by +10.01%
Increased by +18.03%
Decreased by -8.59%
Dec 31, 21 40.29 M
Increased by +24.97%
8.13 M
Increased by +10.27%
Increased by +20.17%
Decreased by -11.76%
Sep 30, 21 42.85 M
Increased by +26.85%
8.28 M
Increased by +14.28%
Increased by +19.31%
Decreased by -9.91%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.